Skip to main content

Table 1 Characteristics of included patients and gliomas

From: Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma

Group Total (n = 40) Pre-treatment group (n = 20) Post-treatment group (n = 20)
Mean age at imaging ± standard deviation (years) 61 ± 13.6 61 ± 13.2 60 ± 13.4
Gender (n, %)
 F n = 24, 60% n = 13, 65% n = 11, 55%
 M n = 16,40% n = 7, 35% n = 9, 45%
Histologically confirmed diagnosis (n, %) WHO II: 8, 20%
WHO III: 2, 5%
WHO IV: 30, 75%
WHO II: 4, 20%
WHO III: 1, 5%
WHO IV: 15, 75%
WHO II: 4, 20%
WHO III: 1, 5%
WHO IV: 15, 75%